The use of vaccines for prevention of seasonal and pandemic influenzaArchived
On 3 October 2011 European Centre for Disease Prevention and Control (ECDC) and representatives of the European Vaccine Manufacturers met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of seasonal and pandemic influenza. ECDC Director Marc Sprenger opened the meeting and ECDC influenza experts held different presentations, such as burden of influenza disease in the EU, risk groups for severe influenza disease, personal protective measures, pandemic influenza preparedness, seasonal influenza vaccines, communication.
The Declarations of Interest for ECDC Influenza Staff and the ECDC Director are available here under ECDC Transparency.
4th Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting 2014
WHO/Europe has been holding annual influenza surveillance meetings jointly with the European Centre for Disease Prevention and Control (ECDC) since 2011. This meeting brought together epidemiologists and virologists – the national influenza surveillance focal points – from 50 Member States to discuss national, regional and global surveillance related to seasonal influenza and novel influenza viruses, such as avian influenza A(H7N9).
Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines
This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.
The role of social networks in pandemic influenza transmission in and from schools – an example from the United StatesArchived
While there have been some early descriptive reports of school outbreaks, for example a number published in Eurosurveillance from France and the UK this study is unusual in combining modelling, social network theory and ‘shoe-leather epidemiology’.
Evidence from autopsies on the pathogenesis and pathological findings of the 2009 pandemic influenza A(H1N1) – implications for clinical care and disease burdenArchived
The first study, conducted in Europe during the 2009 pandemic addressed several objectives concerning the pathogenesis of the disease caused by the influenza A(H1N1) 2009 viruses.
Pandemic influenza A(H1N1) 2009 – the experience and pressure on Intensive Care Units (ICU’s) - implications for specialists in critical careArchived
The journal Critical Care Medicine has recently published a supplement of open access articles on the experience in intensive care units during the 2009 pandemic of influenza.
Field and epidemiological investigations during the 2009 influenza pandemic conducted in the United States: similar approaches in diverse settingsArchived
This paper serves as a gateway review of several field and epidemiological investigations conducted across the United States (US) which have been compiled as a special supplement in a January 2011 number of the Clinical Infectious Diseases journal.
Obesity and 2009 pandemic influenza A(H1N1) – its role and implications as an important risk factor for the development of severe influenza diseaseArchived
2 papers are reviewed: A Novel Risk Factor for a Novel Virus: Obesity and 2009 Pandemic Influenza A (H1N1) and Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease.
No association found between pandemic influenza vaccination and Guillain-Barre Syndrome in EuropeArchived
Due to an association that was observed in the United States between a swine-flu based human influenza vaccine developed in 1976 and the disease acute polyneuropathy Guillain-Barré syndrome (GBS) (1,2), GBS was one of the adverse events that was monitored in Europe and North America (3) following the 2009 influenza pandemic vaccination campaigns.
Recent findings about the clinical consequences of the 1918 pandemic – two further studies describing male autopsy results and female birth rate decline and miscarriagesArchived
The 1918 pandemic continues to provide a rich source of studies of the clinical impact of those novel viruses which between 1918 and 1920 killed up to 50 million people world-wide. These two recent studies first shows autopsy results among military recruits who died from the first influenza pandemic of the 20th century and the second suggests the impact on births.